ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ロメフロキサシン

Lomefloxacin

HCID 3948
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
98079-51-7
標準SMILES
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21
InChIKey
ZEKZLJVOYLTDKK-UHFFFAOYSA-N
分子式
C17H19F2N3O3
平均分子量
351.35 g/mol
単同位体質量
351.1394478

概要

Lomefloxacin is a fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery. It has a role as an antitubercular agent, an antimicrobial agent and a photosensitizing agent. It is a quinolone, a quinolinemonocarboxylic acid, a N-arylpiperazine, a quinolone antibiotic and a fluoroquinolone antibiotic.

名称と識別子

優先名称
Lomefloxacin
IUPAC
1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
現地名
ロメフロキサシン
英語名
Lomefloxacin
分子式
C17H19F2N3O3
分子量
351.35

名称と別名

lomefloxacin98079-51-7LomefloxacineLomefloxacinoLomefloxacinumLFLX1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acidSC-47111AL6BR2WJD8V1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acidDTXSID4040680
名称をさらに表示
1-エチル-4-オキソ-6,8-ジフルオロ-7-(3-メチル-1-ピペラジニル)-1,4-ジヒドロキノリン-3-カルボン酸1-エチル-6,8-ジフルオロ-7-(3-メチルピペラジノ)-4-オキソ-1,4-ジヒドロ-3-キノリンカルボン酸1-エチル-6,8-ジフルオロ-1,4-ジヒドロ-7-(3-メチル-1-ピペラジニル)-4-オキソ-3-キノリンカルボン酸1-エチル-6,8-ジフルオロ-1,4-ジヒドロ-7-(3-メチル-1-ピペラジニル)-4-オキソキノリン-3-カルボン酸ロメフロキサシン1-エチル-6,8-ジフルオロ-1,4-ジヒドロ-4-オキソ-7-(3-メチル-1-ピペラジニル)キノリン-3-カルボン酸1-エチル-6,8-ジフルオロ-7-(3-メチルピペラジン-1-イル)-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸1-エチル-6,8-ジフルオロ-1,4-ジヒドロ-4-オキソ-7-(3-メチルピペラジノ)-3-キノリンカルボン酸1,4-ジヒドロ-4-オキソ-1-エチル-6,8-ジフルオロ-7-(3-メチルピペラジン-1-イル)キノリン-3-カルボン酸dm-10ClfimonoSC 47111ALomel9actLEMOFLOXACIN
CHEBI:116278(+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acidLogifloxOkacinSC-4711lomefloxacinalomenfloxacinRefChem:153984

物性

構造計算による物性

XLogP
-0.8
極性表面積
72.9 Ų
水素結合供与体数
2
水素結合受容体数
8
回転可能結合数
3
重原子数
25
形式電荷
0
複雑度
585

実験および物理化学的性質

Drugs · 2 件

Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use

Pharmaceuticals -> Antibiotics

LogP2.8
Solubility1.06e-01 g/L
Human DrugsBreast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Quinolones; Fluoroquinolones
Melting Point · 2 件

239-240.5 °C

239 - 240.5 °C

Physical DescriptionSolid
Dissociation Constants5.742
Collision Cross Section · 2 件

191.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]

191.04 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
239 · 239-240 C
沸点
542.7 · 542.7±50.0 °C(Predicted)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

危険有害性情報

Regulatory InformationREACH registered substance: 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecaboylic acid (EC: 619-317-6)
Hazard Classes and CategoriesAcute Tox. 4 (100%)

毒性情報

Drug Induced Liver Injury · 5 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

lomefloxacin

DILI Negative

Oral

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
EPA Human Health Benchmarks for Pharmaceuticals · 6 件

Lomefloxacin

9.3

39.4

The recommended daily dose of lomefloxacin hydrochloride is 400 mg.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 400 mg/day, Lowest Therapeutic Dose (LTD): 5.0 mg/kg-day, and Screening Dose: 0.002 mg/kg-day.

11-May-06

安全データ

wgk

化学と産業

薬理情報

ATC Code · 4 件

S - Sensory organs

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

QS - Sensory organs

Protein Binding10%
Pharmacodynamics · 1 件

Lomefloxacin is a fluoroquinolone antibiotic used to treat chronic bronchitis, as well as complicated and uncomplicated urinary tract infections. It is also used as a prophylactic or preventative treatment to prevent urinary tract infections in patients undergoing transrectal or transurethral surgical procedures. Flouroquinolones such as lomefloxacin possess excellent activity against gram-negative aerobic bacteria such as <i>E.coli</i> and <i>Neisseria gonorrhoea</i> as well as gram-positive bacteria including <i>S. pneumoniae</i> and <i>Staphylococcus aureus</i>. They also posses effective activity against shigella, salmonella, campylobacter, gonococcal organisms, and multi drug resistant pseudomonas and enterobacter.

Mechanism of Action · 1 件

Lomefloxacin is a bactericidal fluoroquinolone agent with activity against a wide range of gram-negative and gram-positive organisms. The bactericidal action of lomefloxacin results from interference with the activity of the bacterial enzymes DNA gyrase and topoisomerase IV, which are needed for the transcription and replication of bacterial DNA. DNA gyrase appears to be the primary quinolone target for gram-negative bacteria. Topoisomerase IV appears to be the preferential target in gram-positive organisms. Interference with these two topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. As a result DNA replication and transcription is inhibited.

Biological Half-Life8 hours
Metabolism/MetabolitesMinimally metabolized although 5 metabolites have been identified in human urine. 65% appears as the parent drug in urine and 9% as the glucuronide metabolite.
MeSH Pharmacological Classification · 2 件

関連反応

4 件
反応記録を作成
HRID 370714 の反応式
HRID 370714生成物として
HRID 370715 の反応式
HRID 370715反応物として
HRID 370716 の反応式
HRID 370716生成物として
HRID 940195 の反応式
HRID 940195生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
98079-51-7
PubChem CID
3948
DTXSID
DTXSID4040680
ChEMBL
CHEMBL561
ChEBI
CHEBI:116278
UNII
L6BR2WJD8V
EC Number
619-317-6
Nikkaji
J135.046C
比重(密度)
1.342 · 1.342±0.06 g/cm3(Predicted)
貯蔵温度
-20 °C · Keep in dark place,Sealed in dry,Store in freezer, under -20°C
溶解性
DMSO (Slightly), Methanol (Slightly, Heated, Sonicated)
外見
Solid
酸解離定数(Pka)
-0.25 · -0.25±0.20(Predicted)
色
Pale Yellow to Light Yellow
CAS データベース
98079 · 98079-51-7(CAS DataBase Reference)
EPAの化学物質情報
3 · 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo- (98079-51-7)

化学的性質

化学的特性colorless Needles

3
rtecs
VB1997500
毒性
LD50 in mice (mg/kg): 245.6 i.v.; >4000 orally (Itoh)
hs_code
29419000
risk_code
22-36/37/38
hazard_code
Xn,Xi
safety_code
26-36

Substances that inhibit the growth or reproduction of BACTERIA.

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Absorption, Distribution and Excretion · 3 件

Rapid and nearly complete with approximately 95% to 98% of a single oral dose being absorbed.

The urinary excretion of lomefloxacin was virtually complete within 72 hours after cessation of dosing, with approximately 65% of the dose being recovered as parent drug and 9% as its glucuronide metabolite.

271 mL/min/1.73 m2 [creatinine clearance of 110 mL/min/1.73 m2]

Cellular LocationsCytoplasm
応用分野 · 2 件

説明Lomefloxacin is a once-daily, third-generation quinolone antibiotic useful in the treatment of bacterial infections. The new fluorinated quinolone does not interfere with the metabolism of theophylline; it is efficacious against pathogens resistant to cephalosporins, penicillins and aminoglycosides.

使用Anti bacterial.

上流・下流製品情報

上流原料

エタノール2,3,4-トリフルオロアニリンエトキシマロン酸ジエチルエステル無水酢酸N,N-ジメチルホルムアミドアセトンエトキシメチレンマロン酸ジエチル4-フルオロ安息香酸クロロエタントリエチルアミン2-メチルピペラジンジベンジル塩酸ロメフロキサシンテトラフルオロベンゼン2,3,4-トリフルオロニトロベンゼン塩酸ブロモエタンピリジン塩化スルフィニル1,4-ジヒドロ-1-エチル-6,7,8-トリフルオロ-4-オキソキノリン-3-カルボン酸炭酸水素ナトリウム

補足説明

定義ChEBI: A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.